This provider's $19.9M in total Medicare payments ranks in the 99th percentile of Nuclear Medicine providers nationally.
Medicare payments to this provider grew 84% from 2014 to 2023.
65% of their billing comes from a single procedure code (78815 — Nuclear medicine study from skull base to mid-thigh with ct scan).
AI-generated analysis based on Medicare payment data.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $708.76 | $260.80 | 2.72x | $447.96 | $1.6M | 6.1K | 34 |
| 2015 | $681.31 | $246.22 | 2.77x | $435.09 | $1.5M | 6.2K | 35 |
| 2016 | $802.22 | $286.20 | 2.80x | $516.02 | $1.4M | 4.9K | 32 |
| 2017 | $819.64 | $294.24 | 2.79x | $525.40 | $1.7M | 5.7K | 33 |
| 2018 | $865.66 | $314.73 | 2.75x | $550.93 | $1.9M | 6.2K | 34 |
| 2019 | $951.31 | $353.31 | 2.69x | $598.00 | $2.2M | 6.2K | 40 |
| 2020 | $1.0K | $388.81 | 2.58x | $615.25 | $1.9M | 4.9K | 32 |
| 2021 | $1.1K | $429.34 | 2.54x | $659.36 | $2.2M | 5.1K | 31 |
| 2022 | $1.2K | $489.07 | 2.43x | $699.91 | $2.5M | 5.2K | 31 |
| 2023 | $1.1K | $475.93 | 2.36x | $646.78 | $2.9M | 6.1K | 29 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | 11.4K | $12.5M | $1.1K | 2.51x |
| A9595 | Piflufolastat f-18, diagnostic, 1 millicurie | 1.7K | $1.1M | $649.40 | 1.40x |
| 78816 | Nuclear medicine study whole body with ct scan | 933 | $1.1M | $1.2K | 2.50x |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 9.5K | $716.1K | $75.66 | 6.22x |
| A9588 | Fluciclovine f-18, diagnostic, 1 millicurie | 388 | $682.9K | $1.8K | 1.41x |
| 78306 | Nuclear medicine study of bone and/or joint whole body | 3.6K | $668.5K | $187.83 | 2.69x |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | 8.0K | $522.7K | $65.73 | 3.79x |
| 78315 | Nuclear medicine study of bone taken at different times | 1.9K | $442.6K | $237.21 | 2.51x |
| 78227 | Nuclear medicine study of liver and bile duct system with use of drugs | 1.4K | $265.5K | $192.93 | 2.93x |
| 78264 | Nuclear medicine study of stomach to assess emptying | 1.1K | $228.0K | $208.99 | 2.52x |
| 78582 | Nuclear medicine study of lung ventilation and circulation | 2.4K | $149.5K | $62.87 | 3.52x |
| 78608 | Nuclear medicine study of brain with metabolic evaluation | 121 | $149.2K | $1.2K | 2.38x |
| 78226 | Nuclear medicine study of liver and bile duct system | 917 | $115.7K | $126.14 | 3.18x |
| A9562 | Technetium tc-99m mertiatide, diagnostic, per study dose, up to 15 millicuries | 443 | $106.5K | $240.49 | 3.91x |
| 78014 | Nuclear medicine study of thyroid and thyroid function | 534 | $91.4K | $171.11 | 2.77x |
| 78708 | Nuclear medicine study of kidney, blood, flow, and function with drug administration | 701 | $90.9K | $129.67 | 3.37x |
| 78071 | Nuclear medicine study of parathyroid with spect | 298 | $86.0K | $288.58 | 3.59x |
| A9584 | Iodine 1-123 ioflupane, diagnostic, per study dose, up to 5 millicuries | 44 | $85.2K | $1.9K | 1.55x |
| A9503 | Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | 3.1K | $84.7K | $26.98 | 1.53x |
| A9587 | Gallium ga-68, dotatate, diagnostic, 0.1 millicurie | 560 | $77.0K | $137.57 | 1.58x |
This provider submits charges 2.61 times higher than what Medicare actually pays.
A markup ratio of 2.61x means for every $100 Medicare pays, this provider initially charges $261. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data